ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 38890455

Digital spatial profiling of the microenvironment of muscle invasive bladder cancer.

Eyers M and 8 others. Commun Biol, 2024. Cited by 9 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Digital spatial profiling of the microenvironment of muscle invasive bladder cancer. Papers, record 38890455. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38890455

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Digital spatial profiling of the microenvironment of muscle invasive bladder cancer.
PubMed
Journal
Commun Biol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.9, provisional
iCite
Revised in PubMed
2024-12-17
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Eyers MMichaelhttps://orcid.org/0000-0002-9021-3901
2Irlam JJoely
3Marshall GGaylehttps://orcid.org/0000-0002-5839-1150
4Smith VVickyhttps://orcid.org/0000-0002-9336-6946
5Baker AAlexanderhttps://orcid.org/0000-0002-3198-6779
6Frost LLucy
7Hoskin PPeterhttps://orcid.org/0000-0001-8323-9567
8Choudhury AAnanya
9West CCatharinehttps://orcid.org/0000-0002-0839-3449

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Urinary Bladder NeoplasmsMajor topic
Tumor MicroenvironmentMajor topic
Humans
Neoplasm Invasiveness
Gene Expression Profiling
Transcriptome
Gene Expression Regulation, Neoplastic
Signal Transduction

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132,460,812Single-cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patient.Genome Med2020https://conductscience.org/library/papers/32460812PubMed
234,108,545Expression pattern and prognostic impact of glycoprotein non-metastatic B (GPNMB) in triple-negative breast cancer.Sci Rep2021https://conductscience.org/library/papers/34108545PubMed
336,358,805Use of High-Plex Data Reveals Novel Insights into the Tumour Microenvironment of Clear Cell Renal Cell Carcinoma.Cancers (Basel)2022https://conductscience.org/library/papers/36358805PubMed
429,514,839Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer.Clin Cancer Res2018https://conductscience.org/library/papers/29514839PubMed
534,381,231Exploring tissue architecture using spatial transcriptomics.Nature2021https://conductscience.org/library/papers/34381231PubMed
624,336,805Causal analysis approaches in Ingenuity Pathway Analysis.Bioinformatics2014https://conductscience.org/library/papers/24336805PubMed
733,597,522Inference and analysis of cell-cell communication using CellChat.Nat Commun2021https://conductscience.org/library/papers/33597522PubMed
821,308,147A four-gene signature predicts disease progression in muscle invasive bladder cancer.Mol Med2011https://conductscience.org/library/papers/21308147PubMed
928,400,426A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer Patients.Clin Cancer Res2017https://conductscience.org/library/papers/28400426PubMed
1023,773,411Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial.Radiother Oncol2013https://conductscience.org/library/papers/23773411PubMed

1 to 10 of 36

See all 36 references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42,874,537Single-cell and spatial transcriptomics reveal a DLL4-associated tip-like endothelial niche linked to neoadjuvant chemotherapy non-response in muscle-invasive bladder cancer.Transl Oncol2026https://conductscience.org/library/papers/42874537PubMed
42,771,603
A recurrent cancer-associated fibroblast/TGF-beta/endothelial barrier direction is associated with immune exclusion and checkpoint resistance in bladder cancer: a public multi-cohort transcriptomic study.
PLoS One2026https://conductscience.org/library/papers/42771603PubMed
42,624,954Biofabrication for spatial control of multiscale biological crosstalk in tissue models.NPJ Biomed Innov2026https://conductscience.org/library/papers/42624954PubMed
42,292,383From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer.Front Immunol2026https://conductscience.org/library/papers/42292383PubMed
41,930,337Antibody-Drug Conjugates in Oncology: Principles, Clinical Development, and Future Directions.MedComm (2020)2026https://conductscience.org/library/papers/41930337PubMed
41,685,329Transcriptome and single-cell RNA sequencing analysis with 101 machine learning combinations and experimental verification reveals the mechanism of action of mannose metabolism in bladder cancer.Front Immunol2026https://conductscience.org/library/papers/41685329PubMed
40,199,763ROICellTrack: a deep learning framework for integrating cellular imaging modalities in subcellular spatial transcriptomic profiling of tumor tissues.Bioinformatics2025https://conductscience.org/library/papers/40199763PubMed
40,034,247Single-cell RNA sequencing and spatial transcriptome analysis in bladder cancer: Current status and future perspectives.Bladder Cancer2025https://conductscience.org/library/papers/40034247PubMed
39,971,624Sarcomatoid areas of urothelial carcinoma are enriched for CD163-positive antigen-presenting cells.J Pathol Clin Res2025https://conductscience.org/library/papers/39971624PubMed
39,272,908Evaluating Treatment Patterns and the Role of Neoadjuvant Chemotherapy in Plasmacytoid Urothelial Carcinoma: Insights from a Combined National and Institutional Series.Cancers (Basel)2024https://conductscience.org/library/papers/39272908PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
VEGFA7,422PubTator's text mininghttps://conductscience.org/library/genes/7422

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38890455

GET https://conductscience.org/api/papers/v1/38890455/references?page=2

API referenceFor AI assistants